Lataa...
Histologic transformation of lung cancer during pembrolizumab therapy: A case report
Immune checkpoint inhibitors that block the programmed death 1/programmed death ligand 1 pathways are widely used to treat advanced lung cancers. There are seldom cases of histologic transformation reported after treatment with immunotherapy. Here, we report the case of a 69‐year‐old man with stage...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2020-03-01
|
| Sarja: | Thoracic Cancer |
| Aiheet: | |
| Linkit: | https://doi.org/10.1111/1759-7714.13312 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|